Seres Therapeutics, Inc. (MCRB) [Rocket]

Date Filed	Type	Description
04/09/2019	GN	Consolidated Research: 2019 Summary Expectations for Wyndham Hotels & Resorts, Apellis Pharmaceuticals, Transcat, Emerald Expositions Events, Capitala Finance, and Seres Therapeutics — Fundamental Analysis, Key Performance Indications
08/24/2018	GN	Factors of Influence in 2018, Key Indicators and Opportunity within Seres Therapeutics, Barnes & Noble, Carbo Ceramics, BioLife Solutions, CareDx, and Syntel — New Research Emphasizes Economic Growth
06/19/2018	GN	Report: Exploring Fundamental Drivers Behind Diamondback Energy, Global Net Lease, Ambac Financial Group, IDACORP, Francesca's, and Seres Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
05/17/2018	BW	Seres Therapeutics to Host Microbiome R&D Event and Webcast on May 24, 2018
05/09/2018	BW	Seres Therapeutics Reports First Quarter Financial Results and Provides Operational Updates
04/25/2018	GN	New Research Coverage Highlights BWX Technologies, Sparton, Mercury General, Seres Therapeutics, Caleres, and GCP Applied Technologies — Consolidated Revenues, Company Growth, and Expectations for 2018
03/08/2018	BW	Seres Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates
03/02/2018	BW	Seres Therapeutics to Host Fourth Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on March 8, 2018
02/26/2018	GN	Report: Developing Opportunities within AeroVironment, Seres Therapeutics, HFF, Fluor, KB Home, and H. B. Fuller — Future Expectations, Projections Moving into 2018
12/19/2017	GN	Report: Exploring Fundamental Drivers Behind Allstate, Ashford Hospitality Prime, S&P Global, Enzo Biochem, Seres Therapeutics, and HFF — New Horizons, Emerging Trends, and Upcoming Developments
11/08/2017	BW	Seres Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Operational Progress
11/02/2017	BW	Seres Therapeutics to Host Third Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on November 8, 2017
10/02/2017	BW	Seres Therapeutics Reports Positive Topline Results from SER-287 Phase 1b Study in Patients with Ulcerative Colitis
08/31/2017	BW	Seres Therapeutics to Present at the Baird 2017 Global Healthcare Conference
08/03/2017	BW	Seres Therapeutics Reports Second Quarter 2017 Financial Results and Provides Update on Operational Progress
07/27/2017	BW	Seres Therapeutics to Host Second Quarter 2017 Financial Results and Operational Progress Conference Call and Webcast on August 3, 2017